Dyslipidemia in the Elderly: Special Insights to Inform the Management Strategy Michael H. Shannon William R. Hazzard The progressive and dramatic aging of the American population over the last century,…
Dyslipidemia and Atherosclerosis in Women Christian D. Nagy Catherine Y. Campbell Roger S. Blumenthal Cardiovascular disease (CVD) remains the number one killer of American women and coronary heart disease (CHD)…
Dyslipidemia in Children and Adolescents Peter O. Kwiterovich Jr. Sarah B. Clauss Brian W. McCrindle This chapter presents a theoretical and practical approach to the diagnosis and treatment of dyslipidemia…
Dyslipidemia in Renal Disease Jeffrey M. Saland Rulan S. Parekh Dyslipidemias have been commonly described in patients with chronic kidney disease (CKD) since the 1960s, with case reports demonstrating markedly…
Pathophysiology and Treatment of Dyslipidemia in Diabetes Sherita Hill Golden Miguel Munoz Atherosclerosis is the leading cause of death among individuals with diabetes, accounting for 80% of all mortality. Approximately…
Disorders of HDL Metabolism Scott M. Lilly Daniel J. Rader Observational and epidemiologic studies have strongly implicated a low level of high-density lipoprotein cholesterol (HDL-C) as an independent risk factor…
Disorders of LDL Metabolism Peter O. Kwiterovich Jr. Peter J. Espenshade Almost 100 years have passed since the classic experiments of Anitschkow and Chalatow (see Ref. 1 for review) who…
Disorders of Hypertriglyceridemia Michael A. Miller In 1959, Drs. Albrink and Mann reported the first association between elevated triglycerides (TG) and cardiovascular disease (CVD) (1). Subsequent case-control and longitudinal studies…
Use of Noninvasive Methods to Diagnose Cardiovascular Disease in Dyslipidemic Patients Ilan Gottlieb João A.C. Lima The effect of higher levels of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C)…
Clinical Trial Evidence for Treatment of Dyslipidemia in the Prevention of Cardiovascular Disease Thomas A. Pearson Randomized trials with well-defined clinical end points provide the strongest proof that a purported…
